Meitheal Pharmaceuticals specializes in research, manufacturing, and supply of injection medicine.
Meitheal Pharmaceuticals has raised $35.0M in total funding. The most recent round was Debt Financing. The last funding was announced in August 2023.
Meitheal Pharmaceuticals's investors include JP Morgan.
Meitheal Pharmaceuticals is headquartered in Chicago, United States.
Meitheal Pharmaceuticals specializes in research, manufacturing, and supply of injection medicine.
Meitheal Pharmaceuticals is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Meitheal Pharmaceuticals — Funding & Investors." VCBacked, August 22, 2023, https://www.vcbacked.co/company/meitheal-pharmaceuticals. Accessed October 29, 2026.
VCBacked. (2023). Meitheal Pharmaceuticals — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/meitheal-pharmaceuticals
{{cite web |title=Meitheal Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/meitheal-pharmaceuticals |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated